Novo Nordisk Shares Post Worst Ever Week as Optimism Wanes | Company Business News
(Bloomberg) -- Just six weeks ago, things seemed to be getting better…
Who is Maziar Mike Doustdar? Novo Nordisk names new CEO to tackle ‘market challenges’ | Company Business News
Danish drug-making company Novo Nordisk has named Mazir Mike Doustdar as its…
Torrent aims to be among first cos to launch Wegovy, Ozempic generics in Brazil
Torrent Pharmaceuticals Ltd aims to be in the first wave of generic…
Novo Nordisk-DRL case on semaglutide takes a fresh turn
The ongoing patent-infringement battle between Novo Nordisk and Dr Reddy’s Laboratories (DRL)…
Cipla to enter into weight management segment in India, says MD Umang Vohra | Company Business News
Drugmaker Cipla’s MD and global CEO Umang Vohra has announced that the…
Novo Nordisk stirs up the weightloss drugs segment in India with Wegovy
Vikrant Shrotriya, Corporate Vice President and Managing Director, Novo Nordisk India Mumbai Danish healthcare company…
Novo Nordisk exits obesity-drug partnership with Hims & Hers, cites compounding concerns | Company Business News
Danish drugmaker Novo Nordisk A/S said on Monday it is terminating a…
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects | Company Business News
CagriSema shows mild-to-moderate side effects in trials Researcher sees benefit to additional…
Not Ozempic, in India THIS weigh-loss and diabetes drug from Eli Lilly sees sales jump 60% — what is it? | Company Business News
While rival Ozempic has made international headlines for its weightloss use, in…
A ‘test case’ unfolds over Novo Nordisk’s weight loss and diabetes drug semaglutide
Semaglutide is the active ingredient in globally popular drug Ozempic/Wegovy | Photo…